APA (7th ed.) Citation

Narukawa, T., Hongo, F., Fujihara, A., Ueno, A., Matsugasumi, T., & Ukimura, O. (2020). Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma. Karger Publishers.

Chicago Style (17th ed.) Citation

Narukawa, Tsukasa, Fumiya Hongo, Atsuko Fujihara, Akihisa Ueno, Toru Matsugasumi, and Osamu Ukimura. Pazopanib After Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma. Karger Publishers, 2020.

MLA (9th ed.) Citation

Narukawa, Tsukasa, et al. Pazopanib After Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma. Karger Publishers, 2020.